1/2/14

SECTION 2: Hazards identification

Emergency Overview: Clear, yellow-amber liquid. WARNING! May cause eye irritation and possibly burns. May cause skin and respiratory tract irritation. May cause an allergic skin reaction. Harmful or fatal if swallowed. Harmful if inhaled or absorbed through the skin. PRIMARY ROUTES OF ENTRY: Eye contact, skin contact, ingestion, and inhalation of product mists TARGET ORGANS: Eye, skin, respiratory system, liver, kidney, and central nervous system

Potential health effects

Eyes: Contact with this product may cause eye irritation and possibly eye burns. Skin: Contact with this product may cause skin irritation. Massive contact with damaged skin or of material sufficiently hot to burn skin may result in the absorption of potentially lethal amounts of the product component, ethylene glycol. Ingestion: Ingestion may cause irritation of the mucous membranes of the mouth, throat, esophagus, and stomach. Nausea, vomiting, and diarrhea may occur. This product contains ethylene glycol. Ingestion of large volumes of ethylene glycol may result in central nervous system depression and kidney damage. Cardiac failure and pulmonary edema may develop. Early to moderate CNS depression may be evidenced by giddiness, headache, dizziness, and nausea. Kidney damage may be evidenced by changes in urine output, urine appearance, or edema (swelling from fluid retention). Inhalation: This product is not expected to present an inhalation hazard unless mists or vapors are generated. Significant air concentrations are not achieved unless the product is heated or sprayed as a mist. Exposure to vapors or mists may cause throat irritation, coughing, sneezing, runny nose, headache, nausea, vomiting, dizziness, drowsiness, central nervous system depression, pulmonary edema, involuntary eye movement, and/or coma. Severe exposure may result in damage to lung tissue. Chronic Exposure: No information is available for this product. Information on components follows. Repeated small exposures to the ethylene glycol by any route can cause severe kidney problems. Brain damage may also occur. Skin allergy can develop. Exposure may damage a developing fetus. Aminotri(methylenephosphonic acid) (ATMP) was fed to rats at 50, 150, or 500 mg/Kg/day for 2 years. Reduced body weights and changes in liver, spleen, and kidney weights or weight ratios were observed in the high-dose group. No adverse histologic, hematologic, biochemical, or urinalysis effects were observed. The no-effect level was considered to be 150 mg/Kg/day. No adverse treatment-related effects on reproduction and no pathologic lesions were observed in either parental animals or pups following dietary administration of ATMP to male and female rats at concentration of 300, 1000, or 3000 ppm throughout premating, mating, gestation, and lactation periods for 3 generations. Some blood effects have been produced by HEDP in chronic feeding studies with rats. A product containing 60% HEDP was administered to beagle dogs at dietary concentrations as high as 10,000 ppm for 90 days with no adverse hematological, biochemical, or histopathological effects. Numerous publications in the scientific literature discuss the effects of HEDP related to bone resorption in tissue and cell culture, and in animals. The effects of HEDP related to bone mineralization, calcium absorption, and metabolism of calcium and phosphate have also been evaluated. Carcinogenicity NTP No ingredients listed in this section IARC No ingredients listed in this section OSHA No ingredients listed in this section

Medical Conditions Generally Aggravated by Exposure

Persons with pre-existing eye problems, skin disorders, or impaired liver, kidney, or respiratory function may be more susceptible to the effects of this substance.